ID: ALA4108142

Max Phase: Preclinical

Molecular Formula: C40H51N7O8

Molecular Weight: 757.89

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  NC(=O)CC[C@@H]1NC(=O)/C=C/C(=O)N[C@H](C(N)=O)CCCCNC(=O)[C@@H](Cc2ccc(C(=O)c3ccccc3)cc2)NC(=O)[C@H](CC2CCCCC2)NC1=O

Standard InChI:  InChI=1S/C40H51N7O8/c41-33(48)19-18-30-39(54)47-32(23-25-9-3-1-4-10-25)40(55)46-31(24-26-14-16-28(17-15-26)36(51)27-11-5-2-6-12-27)38(53)43-22-8-7-13-29(37(42)52)44-34(49)20-21-35(50)45-30/h2,5-6,11-12,14-17,20-21,25,29-32H,1,3-4,7-10,13,18-19,22-24H2,(H2,41,48)(H2,42,52)(H,43,53)(H,44,49)(H,45,50)(H,46,55)(H,47,54)/b21-20+/t29-,30-,31+,32-/m0/s1

Standard InChI Key:  NBNYXFCHNYKOOT-JCBKMTHPSA-N

Associated Targets(Human)

Insulin-degrading enzyme 806 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Insulin-degrading enzyme 20 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 757.89Molecular Weight (Monoisotopic): 757.3799AlogP: 0.98#Rotatable Bonds: 10
Polar Surface Area: 248.75Molecular Species: NEUTRALHBA: 8HBD: 7
#RO5 Violations: 2HBA (Lipinski): 15HBD (Lipinski): 9#RO5 Violations (Lipinski): 3
CX Acidic pKa: 11.90CX Basic pKa: CX LogP: 1.00CX LogD: 1.00
Aromatic Rings: 2Heavy Atoms: 55QED Weighted: 0.17Np Likeness Score: 0.37

References

1.  (2016)  Macrocyclic insulin-degrading enzyme (IDE) inhibitors and uses thereof, 

Source

Source(1):